Inhibitor-Mediated Structural Transition in a Minimal Amyloid Model

Angew Chem Int Ed Engl. 2022 Jan 17;61(3):e202113845. doi: 10.1002/anie.202113845. Epub 2021 Nov 30.

Abstract

Despite the fundamental clinical importance of amyloid fibril formation, its mechanism is still enigmatic. Crystallography of minimal amyloid models was a milestone in the understanding of the architecture and biological activities of amyloid fibers. However, the crystal structure of ultimate dipeptide-based amyloids is not yet reported. Herein, we present the crystal structure of a typical amyloid-forming minimal dipeptide, Ac-Phe-Phe-NH2 (Ac-FF-NH2 ), showing a canonical β-sheet structure at the atomic level. The simplicity of the structure helped in investigating amyloid-inhibition using crystallography, never previously reported for larger peptide models. Interestingly, in the presence of an inhibitor, the supramolecular packing of Ac-FF-NH2 molecules rearranged into a supramolecular 2-fold helix (21 helix). This study promotes our understanding of the mechanism of amyloid formation and of the structural transitions that occur during the inhibition process in a most fundamental model.

Keywords: Amyloid fibril; Crystallization; Dipeptide; Inhibitors; β-Sheet.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / metabolism
  • Cinnamates / chemistry
  • Cinnamates / pharmacology*
  • Depsides / chemistry
  • Depsides / pharmacology*
  • Humans
  • Models, Molecular
  • Particle Size
  • Rosmarinic Acid

Substances

  • Amyloid beta-Peptides
  • Cinnamates
  • Depsides

Grants and funding